Dopamine-Functionalized Cryogel for Wet Tissue Adhesion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing biomaterial-based adhesives for surgical procedures face challenges such as poor tissue integration, biomechanical integration, and toxicity, with gelatin-based adhesives degrading rapidly and causing immunological cytotoxicity, fibrin adhesives having weak adhesion and allergenic risks, and cyanoacrylate adhesives being highly toxic. There is a need for a minimally invasive, robust, and biocompatible wet-tissue adhesive for tissue regeneration.

Innovation Solution

Development of a cryogel comprising a bioadhesive molecule, such as dopamine, covalently linked with a polymerizable moiety, specifically an acrylic acid moiety, which is functionalized to prevent oxidation and enhance adhesion, forming a hydrophilic, injectable, and shape-memory material that can be used for tissue repair and regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If gelatin-based adhesives are used, then robust mechanical properties and biocompatibility are achieved, but poor adhesion to native tissues and rapid degradation leading to immunological cytotoxicity occur

Engineering Contradiction:
Improvemechanical propertiesVSAvoidadhesion to native tissues
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The patent combines gelatin with dopamine functional groups to create a composite adhesive material that leverages the mechanical properties and biocompatibility of gelatin while adding the adhesive capabilities of dopamine to native tissues, thereby resolving the contradiction between mechanical strength and tissue adhesion

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent introduces dopamine functional groups at specific locations within the gelatin structure to enhance adhesion to native tissues without compromising the overall mechanical properties and biocompatibility of the gelatin-based adhesive

Inventive Principle:
Principle #3Local quality

2Reliability

If fibrin adhesives are used, then biocompatibility is achieved, but poor adhesion, weak tensile strength, and allergenic risks occur

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidadhesion and tensile strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent creates a composite material by integrating dopamine functional groups into the fibrin structure, thereby enhancing adhesion and tensile strength while preserving the biocompatibility of fibrin

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies the chemical structure of fibrin by adding dopamine functional groups, changing the material parameters to improve adhesion and tensile strength while maintaining biocompatibility

Inventive Principle:
Principle #35Parameter changes

3Speed

If cyanoacrylate-based adhesives are used, then fast crosslinking and robust bond strengths are achieved, but high toxicity and formaldehyde generation occur

Engineering Contradiction:
Improvecrosslinking speedVSAvoidtoxicity
Core Design Contradiction:
SpeedVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical composition of the adhesive by incorporating dopamine functional groups, which enable fast crosslinking similar to cyanoacrylate but without the associated toxicity and formaldehyde generation, thereby resolving the contradiction between crosslinking speed and toxicity

Inventive Principle:
Principle #35Parameter changes

4Reliability

If DOPA is incorporated to improve adhesion, then wet-surface adhesion is enhanced, but susceptibility to oxidation increases

Engineering Contradiction:
Improveadhesion to wet surfacesVSAvoidoxidation resistance
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent introduces antioxidants as intermediary substances that protect the DOPA functional groups from oxidation, thereby maintaining the adhesion-enhancing properties of DOPA while preventing its degradation through oxidation

Inventive Principle:
Principle #24Intermediary (Mediator)

5Volume of stationary object

If hydrogels undergo crosslinking at subzero temperatures to achieve larger pore size, then cellular infiltration is facilitated, but mechanical strength is reduced

Engineering Contradiction:
Improvepore sizeVSAvoidmechanical strength
Core Design Contradiction:
Volume of stationary objectVSStrength

Solution Approach 1:

The patent creates a composite cryogel structure that combines the porous network formed during subzero crosslinking with reinforcing elements that maintain mechanical strength, thereby achieving both large pore sizes for cellular infiltration and adequate mechanical properties

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The cryogel achieves improved wet-tissue adhesion, biocompatibility, and tissue integration, reducing the need for invasive procedures and promoting efficient tissue regeneration with minimal cytotoxicity and immunological complications, outperforming commercial biomaterials in adhesion strength and stability.

Implementation Method 1

Hydrogels undergo crosslinking at subzero temperatures. This process is referred to as cryogelation.

Methodology Applied
Scientific EffectCryogelation: Freezing

Implementation Method 2

DOPA and PDA have been shown to adhere to both organic and inorganic surfaces and have been incorporated into a variety of polymers including gelatin and hyaluronic acid.

Methodology Applied
Scientific EffectAdhesion: Adhesive

Data Source

PatentUS11850325B2Injectable, bioadhesive cryogel scaffolds for biomedical uses
Publication Date: 2023.12.26 NORTHEASTERN UNIV (US)
  • US11850325B2 patent drawing
  • US11850325B2 patent drawing
  • US11850325B2 patent drawing

AI summary

Disclosed herein are functionalized dopamine derivatives comprising an optionally substituted acrylic acid moiety and optionally a polyethylene glycol linking moiety. The functionalized dopamine derivatives are useful in cryogel formulations to improve the adhesivity of the cryogel, while preventing undesirable oxidation typically associated with dopamine-containing hydrogels and cryogels. Properties such as cryogel adhesivity, pore size, and interconnectivity are tunable features. Also provided herein are methods of treating a wound or promoting tissue regeneration with a cryogel of the invention or a formulation comprising such a cryogel.